List of Excipients in API loxapine succinate
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing loxapine succinate
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Marlex Pharmaceuticals Inc | loxapine succinate | 10135-585 | ALCOHOL |
| Marlex Pharmaceuticals Inc | loxapine succinate | 10135-585 | AMMONIA |
| Marlex Pharmaceuticals Inc | loxapine succinate | 10135-585 | ANHYDROUS LACTOSE |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for loxapine succinate
Excipient focus: ALCOHOL
loxapine succinate drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | loxapine succinate | 10135-585 |
| >Company | >Ingredient | >NDC |
loxapine succinate drug variants not containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: AMMONIA
loxapine succinate drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | loxapine succinate | 10135-585 |
| >Company | >Ingredient | >NDC |
loxapine succinate drug variants not containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS LACTOSE
loxapine succinate drug variants containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | loxapine succinate | 10135-585 |
| >Company | >Ingredient | >NDC |
loxapine succinate drug variants not containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYL ALCOHOL
loxapine succinate drug variants containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | loxapine succinate | 10135-585 |
| >Company | >Ingredient | >NDC |
loxapine succinate drug variants not containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: D&C RED NO. 33
loxapine succinate drug variants containing D&C RED NO. 33
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | loxapine succinate | 10135-585 |
| >Company | >Ingredient | >NDC |
loxapine succinate drug variants not containing D&C RED NO. 33
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
loxapine succinate drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | loxapine succinate | 10135-585 |
| >Company | >Ingredient | >NDC |
loxapine succinate drug variants not containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: DIMETHICONE
loxapine succinate drug variants containing DIMETHICONE
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | loxapine succinate | 10135-585 |
| >Company | >Ingredient | >NDC |
loxapine succinate drug variants not containing DIMETHICONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
loxapine succinate drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | loxapine succinate | 10135-585 |
| >Company | >Ingredient | >NDC |
loxapine succinate drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
loxapine succinate drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | loxapine succinate | 10135-585 |
| >Company | >Ingredient | >NDC |
loxapine succinate drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
loxapine succinate drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | loxapine succinate | 10135-585 |
| >Company | >Ingredient | >NDC |
loxapine succinate drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
loxapine succinate drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | loxapine succinate | 10135-585 |
| >Company | >Ingredient | >NDC |
loxapine succinate drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
loxapine succinate drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | loxapine succinate | 10135-585 |
| >Company | >Ingredient | >NDC |
loxapine succinate drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ALCOHOL
loxapine succinate drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | loxapine succinate | 10135-585 |
| >Company | >Ingredient | >NDC |
loxapine succinate drug variants not containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
loxapine succinate drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | loxapine succinate | 10135-585 |
| >Company | >Ingredient | >NDC |
loxapine succinate drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: METHYL ALCOHOL
loxapine succinate drug variants containing METHYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | loxapine succinate | 10135-585 |
| >Company | >Ingredient | >NDC |
loxapine succinate drug variants not containing METHYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLACRILIN POTASSIUM
loxapine succinate drug variants containing POLACRILIN POTASSIUM
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | loxapine succinate | 10135-585 |
| >Company | >Ingredient | >NDC |
loxapine succinate drug variants not containing POLACRILIN POTASSIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
loxapine succinate drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | loxapine succinate | 10135-585 |
| >Company | >Ingredient | >NDC |
loxapine succinate drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
loxapine succinate drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | loxapine succinate | 10135-585 |
| >Company | >Ingredient | >NDC |
loxapine succinate drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
loxapine succinate drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | loxapine succinate | 10135-585 |
| >Company | >Ingredient | >NDC |
loxapine succinate drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
loxapine succinate drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | loxapine succinate | 10135-585 |
| >Company | >Ingredient | >NDC |
loxapine succinate drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
loxapine succinate drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | loxapine succinate | 10135-585 |
| >Company | >Ingredient | >NDC |
loxapine succinate drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
loxapine succinate drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | loxapine succinate | 10135-585 |
| >Company | >Ingredient | >NDC |
loxapine succinate drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
